To enable the analysis of anything, by anyone, anywhere.
Oxford Nanopore Technologies, founded in 2005 as a University of Oxford spin-out, develops a novel generation of DNA and RNA sequencing technology. Its devices — from pocket-sized MinION to high-throughput PromethION — enable real-time, long-read sequencing in any environment. The company, listed on the London Stock Exchange (ONT), employs over 1,300 staff and sells to more than 120 countries across research, clinical, and applied markets.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountSep 2021
May 2021
Dec 2020
Jun 2020
Jan 2020
Oct 2018
Mar 2018
Dec 2016
Jul 2015
Aug 2014
Oct 2013
Apr 2011
Feb 2010
Jan 2009
Mar 2008
Jan 2005
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
Healthcare company applying technology to drug development by building nimble biotech subsidiarie...
Neuralink is building a brain-computer interface for medical needs and greater human potential.
